EE05394B1 - Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis - Google Patents

Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Info

Publication number
EE05394B1
EE05394B1 EEP200500033A EEP200500033A EE05394B1 EE 05394 B1 EE05394 B1 EE 05394B1 EE P200500033 A EEP200500033 A EE P200500033A EE P200500033 A EEP200500033 A EE P200500033A EE 05394 B1 EE05394 B1 EE 05394B1
Authority
EE
Estonia
Prior art keywords
treatment
quinoline compounds
latent tuberculosis
tuberculosis
latent
Prior art date
Application number
EEP200500033A
Other languages
English (en)
Inventor
Jozef Lodewijk Marcel Andries Koenraad
Koul Anil
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05394(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200500033A publication Critical patent/EE200500033A/et
Publication of EE05394B1 publication Critical patent/EE05394B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
EEP200500033A 2004-12-24 2005-12-05 Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis EE05394B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04078529 2004-12-24
EP05105008 2005-06-08

Publications (2)

Publication Number Publication Date
EE200500033A EE200500033A (et) 2006-08-15
EE05394B1 true EE05394B1 (et) 2011-04-15

Family

ID=35717702

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200500033A EE05394B1 (et) 2004-12-24 2005-12-05 Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Country Status (31)

Country Link
US (1) US20060142279A1 (et)
EP (1) EP1830850B1 (et)
CN (1) CN103142595B (et)
AP (1) AP2327A (et)
AR (1) AR051790A1 (et)
AT (1) ATE501721T1 (et)
AU (1) AU2005242138B2 (et)
BR (1) BRPI0506400B8 (et)
CA (1) CA2529265C (et)
CR (1) CR9267A (et)
CY (1) CY1112247T1 (et)
DE (1) DE602005026984D1 (et)
DK (1) DK1830850T3 (et)
EE (1) EE05394B1 (et)
HK (1) HK1186125A1 (et)
HR (1) HRP20110392T1 (et)
IL (1) IL184123A (et)
LV (1) LV13469B (et)
ME (1) ME01207B (et)
MY (1) MY145845A (et)
NI (1) NI200700146A (et)
NO (1) NO340376B1 (et)
NZ (1) NZ555460A (et)
PA (1) PA8654801A1 (et)
PL (1) PL1830850T3 (et)
PT (1) PT1830850E (et)
RS (1) RS51730B (et)
SI (1) SI1830850T1 (et)
TR (1) TR200504892A1 (et)
TW (1) TWI404535B (et)
WO (1) WO2006067048A1 (et)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1527050B1 (en) * 2002-07-25 2010-04-07 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors
CN101252927B (zh) * 2005-06-28 2014-01-01 詹森药业有限公司 作为抗菌剂的喹啉衍生物
JO2752B1 (en) * 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO3270B1 (ar) * 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2725B1 (en) * 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2970B1 (en) * 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2683B1 (en) * 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
CA2711912A1 (en) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
RU2404971C2 (ru) * 2008-12-02 2010-11-27 ЗАО "Фарм-Синтез" Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
WO2010083436A1 (en) 2009-01-15 2010-07-22 Rutgers, The State University Of New Jersey Benzo [c] phenanthridines as antimicrobial agents
WO2010127307A1 (en) 2009-04-30 2010-11-04 Rutgers, The State University Of New Jersey Antimicrobial agents
US8933096B2 (en) 2010-06-09 2015-01-13 Rugers, The State University of New Jersey Antimicrobial agents
US9102617B2 (en) 2010-06-25 2015-08-11 Rutgers, The State University Of New Jersey Antimicrobial agents
WO2013106756A2 (en) 2012-01-13 2013-07-18 Rutgers, The State University Of New Jersey Antimicrobial agents
AU2013235038A1 (en) 2012-03-21 2014-10-09 Malvika Kaul Antimicrobial agents
CA2869718C (en) 2012-04-27 2021-05-11 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
US9617244B2 (en) 2012-04-27 2017-04-11 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
US9458150B2 (en) 2013-11-08 2016-10-04 Rutgers, The State University Of New Jersey Antimicrobial agents
IL253626B1 (en) 2015-01-27 2024-04-01 Janssen Pharmaceutica Nv dispersible preparations
EP3419967A4 (en) 2016-02-25 2019-10-16 Taxis Pharmaceuticals, Inc. METHODS AND INTERMEDIARIES FOR SYNTHESIS
US10508097B2 (en) * 2016-03-07 2019-12-17 The Global Alliance For Tb Drug Development, Inc. Antibacterial compounds and uses thereof
RU2629369C1 (ru) * 2016-10-05 2017-08-29 Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
WO2018183917A1 (en) 2017-03-30 2018-10-04 Taxis Pharmaceuticals, Inc. Synthetic processes and synthetic intermediates
DK3651736T3 (da) 2017-07-14 2021-09-27 Janssen Pharmaceutica Nv Langtidsvirkende formuleringer
RU2661151C1 (ru) * 2017-12-14 2018-07-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
JP2022516671A (ja) 2019-01-09 2022-03-01 ヤンセン ファーマシューティカ エヌ．ベー． 非結核性抗酸菌症の処置における組合せ
WO2022008645A1 (en) 2020-07-09 2022-01-13 Janssen Pharmaceutica Nv Long-acting formulations
KR20230038521A (ko) 2020-07-09 2023-03-20 얀센 파마슈티카 엔.브이. 장기 작용 제형
JP2023549605A (ja) 2020-11-12 2023-11-28 ヤンセン ファーマシューティカ エヌ．ベー． 非結核性マイコバクテリア疾患の治療におけるベダキリン、エタンブトール、及びマクロライドの組合せ
WO2023232838A1 (en) 2022-05-31 2023-12-07 Janssen Pharmaceutica Nv Bedaquiline for use in the treatment of leprosy
WO2024068693A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations
WO2024068699A1 (en) 2022-09-28 2024-04-04 Janssen Pharmaceutica Nv Long-acting formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
EP1527050B1 (en) * 2002-07-25 2010-04-07 Janssen Pharmaceutica N.V. Quinoline derivatives and their use as mycobacterial inhibitors

Also Published As

Publication number Publication date
CA2529265A1 (en) 2006-06-24
EE200500033A (et) 2006-08-15
NZ555460A (en) 2008-11-28
PL1830850T3 (pl) 2011-07-29
CN103142595A (zh) 2013-06-12
HK1186125A1 (en) 2014-03-07
PA8654801A1 (es) 2006-08-03
HRP20110392T1 (hr) 2011-06-30
TW200637551A (en) 2006-11-01
AR051790A1 (es) 2007-02-07
EP1830850B1 (en) 2011-03-16
LV13469B (en) 2007-01-20
EP1830850A1 (en) 2007-09-12
AU2005242138A1 (en) 2006-07-13
RS51730B (en) 2011-10-31
NO340376B1 (no) 2017-04-10
AU2005242138B2 (en) 2011-05-26
BRPI0506400B8 (pt) 2021-05-25
MY145845A (en) 2012-04-30
CR9267A (es) 2008-09-09
CA2529265C (en) 2014-02-11
IL184123A0 (en) 2008-12-29
DK1830850T3 (da) 2011-06-14
BRPI0506400B1 (pt) 2021-04-06
US20060142279A1 (en) 2006-06-29
DE602005026984D1 (de) 2011-04-28
SI1830850T1 (sl) 2011-07-29
WO2006067048A1 (en) 2006-06-29
AP2327A (en) 2011-11-25
AP2007004054A0 (en) 2007-06-30
CN103142595B (zh) 2015-05-06
CY1112247T1 (el) 2015-12-09
BRPI0506400A8 (pt) 2017-09-12
NO20073823L (no) 2007-07-23
ATE501721T1 (de) 2011-04-15
BRPI0506400A (pt) 2006-08-29
TR200504892A1 (tr) 2010-04-21
TWI404535B (zh) 2013-08-11
PT1830850E (pt) 2011-05-31
IL184123A (en) 2011-10-31
ME01207B (me) 2013-03-20
NI200700146A (es) 2019-05-10

Similar Documents

Publication Publication Date Title
EE05394B1 (et) Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CY2017013I1 (el) ΑΝΤΙΣΩΜΑ ΕΝΑΝΤΙΟΝ PDGFR-α ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΟΓΚΩΝ
DK1720554T3 (da) Anvendelse af meloxicam til behandling af luftvejssygdomme hos svin
IL181524A0 (en) Heterocyclic compounds and methods of use
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DE602005018315D1 (de) Rollstuhl
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
ZA200705160B (en) Quinoline derivatives for the treatment of latent tuberculosis
DK2301576T3 (da) Terapeutisk anvendelse af anti-CS1-antistoffer
SE0400718D0 (sv) Therapeutic agents
SE0403119D0 (sv) Therapeutic agents
DE602005016381D1 (de) Hüllenelement und kassette
SE0400613D0 (sv) New compounds and use thereof
SE0402780D0 (sv) Therapeutic agents
EE200400064A (et) Ambroksooli kasutamine neelupõletiku ravimiseks
SE0402392D0 (sv) New use
SE0401715D0 (sv) New use
SE0403161L (sv) Ny användning av glucosine
FR2870073B1 (fr) Disque dur partage
SE0402247D0 (sv) Rullstol
SE0402678D0 (sv) Pharmaceutical use

Legal Events

Date Code Title Description
HC1A Change of owner name